Trends in Antiparkinsonian Medication Use in New Zealand: 1995–2011

Trends in Antiparkinsonian Medication Use in New Zealand: 1995–2011

Prescribing trends for medications are influenced by development of new drugs, changes in knowledge about efficacy and side effects, and priorities set by funding agencies. Changes in the utilization of antiparkinsonian agents in the outpatient community in New Zealand were investigated by using the...

Full description

Bibliographic Details
Main Authors:	T. L. Pitcher, M. R. MacAskill, T. J. Anderson
Format:	Article
Language:	English
Published:	Hindawi Limited 2014-01-01
Series:	Parkinson's Disease
Online Access:	http://dx.doi.org/10.1155/2014/379431

Similar Items

PHARMACOKINETIC STUDIES OF NEW ANTIPARKINSONIAN DRUG RAPITALAM
by: Natalya Avdeeva, et al.
Published: (2016-12-01)

Parkinson's disease diffusion MRI is not affected by acute antiparkinsonian medication
by: Jae Woo Chung, et al.
Published: (2017-01-01)

Importance of Nanoparticles for the Delivery of Antiparkinsonian Drugs
by: Sara Silva, et al.
Published: (2021-04-01)

Trends in incidence of primary brain cancer in New Zealand, 1995 to 2010
by: Stella J‐H Kim, et al.
Published: (2015-04-01)

Plasma and CSF markers of oxidative stress are increased in Parkinson's disease and influenced by antiparkinsonian medication
by: Carsten Buhmann, et al.
Published: (2004-02-01)

Groult, Benoîte. Ainsi soit Olympe de Gouges
by: Annick MacAskill
Published: (2014-12-01)

Moral Uncertainty
by: MacAskill, Michael
Published: (2020)

'A silver fringe?' : the Crown, private proprietors and the Scottish kelp shores and the Scottish foreshore generally c1800-c1940
by: MacAskill, John
Published: (2003)

Groult, Benoîte. Ainsi soit Olympe de Gouges
by: Annick MacAskill
Published: (2014-12-01)

Antiparkinsonian Efficacy of Guanosine in Rodent Models of Movement Disorder
by: Caio M. Massari, et al.
Published: (2017-10-01)

Factors influencing the efficacy of the immune response to Trypanosomiasis
by: MacAskill, J. A.
Published: (1981)

Antiparkinsonian effects of the "Radiprodil and Tozadenant" combination in MPTP-treated marmosets.
by: Anne Michel, et al.
Published: (2017-01-01)

Comparison of the antioxidant potential of antiparkinsonian drugs in different in vitro models
by: Carine Coneglian de Farias, et al.
Published: (2014-12-01)

Whose name is it anyway? Varying patterns of possessive usage in eponymous neurodegenerative diseases
by: Michael R. MacAskill, et al.
Published: (2013-04-01)

Evaluation of the antiparkinsonian effects of maackiain using the pharmacological and transgenic Caenorhabditis elegans models
by: Shao-Hsuan Chien, et al.
Published: (2017)

Relationship of job analysis and position classification to public and private personnel administration
by: MacAskill, Ross Morrison
Published: (2012)

The development of a post-secondary program in health promotion for native peoples
by: MacAskill, Pamela E.
Published: (2013)

Inflammatory and proliferative characteristics of late arteriovenous fistula stenosis : therapeutic potential of diclofenac
by: MacAskill, Mark George
Published: (2014)

Antiparkinsonian drugs as potent contributors to nocturnal sleep in patients with Parkinson's disease.
by: Soutarou Taguchi, et al.
Published: (2021-01-01)

The Antiparkinsonian and Antidyskinetic Mechanisms of Mucuna pruriens in the MPTP-Treated Nonhuman Primate
by: Christopher A. Lieu, et al.
Published: (2012-01-01)

A study of the antiparkinsonian effects of narcissoside using the pharmacological and transgenic Caenorhabditis elegans models
by: Yen-Chuan Chen, et al.
Published: (2018)

The Internet in New Zealand 2011
by: Smith, P, et al.
Published: (2020)

Practical aspects of prescribing antiparkinsonian drugs. The place of amantadines in the management of Parkinson’s disease
by: N. V. Titova, et al.
Published: (2021-03-01)

Inhibitory Effects of Antiparkinsonian Drugs and Caspase Inhibitors in a Parkinsonian Flatworm Model
by: Yoshihisa Kitamura, et al.
Published: (2003-01-01)

Impairment of Serotonergic Transmission by the Antiparkinsonian Drug L-DOPA: Mechanisms and Clinical Implications
by: Cristina Miguelez, et al.
Published: (2017-09-01)

Deciphering the actions of antiparkinsonian and antipsychotic drugs on cAMP/DARPP-32 signaling
by: Gilberto eFisone, et al.
Published: (2011-07-01)

Control of neuronal mitochondrial transport
by: MacAskill, A. F. N.
Published: (2010)

Changes of plasma cGP/IGF‐1 molar ratio with age is associated with cognitive status of Parkinson disease
by: Dawei Fan, et al.
Published: (2020-01-01)

Profile and frequency of antiparkinsonian drugs adverse reactions: a systematic review and meta-analysis
by: A. A. Tappakhov, et al.
Published: (2021-06-01)

The comparative analysis of antiparkinsonian activity of glycine combined with amantadine in conditions of changing neurosynaptic transmission.
by: V. I. Mamchur, et al.
Published: (2017-10-01)

Examining non-medical prescribing trends in New Zealand: 2016–2020
by: Rakhee Raghunandan, et al.
Published: (2021-05-01)

c-Abl Inhibition Exerts Symptomatic Antiparkinsonian Effects Through a Striatal Postsynaptic Mechanism
by: Yu Zhou, et al.
Published: (2018-11-01)

Different functional basal ganglia subcircuits associated with anti-akinetic and dyskinesiogenic effects of antiparkinsonian therapies
by: Emilie Lacombe, et al.
Published: (2009-10-01)

Plasma exosome concentration may correlate with cognitive impairment in Parkinson's disease
by: Yassar Alamri, et al.
Published: (2016-01-01)

Antiparkinsonian action of a selective group III mGlu receptor agonist is associated with reversal of subthalamonigral overactivity
by: S. Lopez, et al.
Published: (2012-04-01)

Motor Improvement-Related Regional Cerebral Blood Flow Changes in Parkinson’s Disease in Response to Antiparkinsonian Drugs
by: Soutarou Taguchi, et al.
Published: (2019-01-01)

An investigation of the potential antiparkinsonian activity of combined dopamine D2 and serotonin 1A receptor agonists
by: Johnston, Louisa Clare
Published: (2004)

Biased Connectivity of Brain-wide Inputs to Ventral Subiculum Output Neurons
by: Ryan W.S. Wee, et al.
Published: (2020-03-01)

Global Update and Trends of Hidden Hunger, 1995-2011: The Hidden Hunger Index.
by: Julie C Ruel-Bergeron, et al.
Published: (2015-01-01)

Staphylococcus aureus Infections in New Zealand, 2000–2011
by: Deborah A. Williamson, et al.
Published: (2014-07-01)

Cannot write session to /tmp/vufind_sessions/sess_vqsqlu4t0cnqbgtbbufhmlhpjl